Search Results - "Medve, Robert A."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral Oxycodone by Webster, Lynn R., Bath, Brad, Medve, Robert A., Marmon, Tonya, Stoddard, Gregory J.

    Published in Pain medicine (Malden, Mass.) (01-06-2012)
    “…Objective.  The objective of this study was to evaluate the pharmacokinetics and abuse potential of different formulations of oxycodone. Design.  The…”
    Get full text
    Journal Article
  2. 2

    Oral tramadol for the treatment of pain of 7-30 days' duration in children by ROSE, John B, FINKEL, Julia C, ARQUEDAS-MOHS, Adriano, HIMELSTEIN, Bruce P, SCHREINER, Mark, MEDVE, Robert A

    Published in Anesthesia and analgesia (2003)
    “…This open-label, multicenter trial was designed to determine the safety profile and analgesic efficacy of tramadol for the treatment of painful conditions…”
    Get full text
    Journal Article
  3. 3

    Opioid formulations in development designed to curtail abuse: who is the target? by Webster, Lynn R, Bath, Brad, Medve, Robert A

    Published in Expert opinion on investigational drugs (01-03-2009)
    “…Opioids are increasingly prescribed for chronic cancer and noncancer pain, and misuse, abuse, and diversion have risen dramatically. Formulations are being…”
    Get more information
    Journal Article
  4. 4

    Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending-dose study by Eldon, Michael A., Kugler, Alan R., Medve, Robert A., Bui, Khanh, Butler, Kathleen, Sostek, Mark

    Published in Clinical pharmacology in drug development (01-11-2015)
    “…This randomized, double‐blind, placebo‐controlled, ascending‐dose, crossover study evaluated single oral doses of naloxegol (NKTR‐118; 8, 15, 30, 60, 125, 250,…”
    Get full text
    Journal Article
  5. 5

    Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol by Eldon, Michael A., Kugler, Alan R., Medve, Robert A., Bui, Khanh, Butler, Kathleen, Sostek, Mark

    Published in Clinical pharmacology in drug development (01-11-2015)
    “…Opioid‐induced constipation (OIC) is the most common and often a treatment‐limiting adverse event (AE) of opioid therapy for chronic pain. Naloxegol…”
    Get full text
    Journal Article
  6. 6

    An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of postsurgical pain in children by FINKEL, Julia C, ROSE, John B, SCHMITZ, Michael L, BIRMINGHAM, Patrick K, ULMA, George A, GUNTER, Joel B, CNAAN, Avital, COTE, Charles J, MEDVE, Robert A, SCHREINER, Mark S

    Published in Anesthesia and analgesia (01-06-2002)
    “…In this double-blinded, randomized, multicenter study, we examined analgesic efficacy and tolerability of tramadol in postoperative pediatric patients…”
    Get full text
    Journal Article
  7. 7
  8. 8